Brinker International and Corcept Therapeutics to move to S&P MidCap 40
Brinker International and Corcept Therapeutics are moving from S&P SmallCap 600 to S&P MidCap 40.
Story updates
09:30:09 PM UTC
SquawkNews
Correct: Brinker International and Corcept Therapeutics Moving to S&P MidCap 400 From S&P SmallCap 600
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.